Integration of machine learning in biomarker discovery for esophageal squamous cell carcinoma: Applications and future directions

Area of Science:

• Oncology
• Bioinformatics
• Medical Informatics

Background:

• Sequencing technologies and bioinformatics have advanced tumor research.
• Large-scale data processing and utilization remain significant challenges.
• Machine learning (ML) offers a novel approach for complex dataset analysis in oncology.

Purpose of the Study:

• Provide an overview of ML methodologies for esophageal squamous cell carcinoma (ESCC) research and management.
• Focus on ML applications in ESCC early detection, prognosis prediction, therapeutic target identification, and drug discovery.
• Examine challenges and opportunities of ML in ESCC research.

Main Methods:

• Comprehensive review of ML processes and methodologies.
• Application-focused analysis for ESCC research.
• Examination of ML integration challenges and opportunities.

Main Results:

• ML techniques can enhance medical decision-making and patient care.
• ML integration in oncology presents challenges requiring interdisciplinary collaboration.
• Coordinated efforts from medical, data science, IT, and policy sectors are needed.

Conclusions:

• ML-driven biomarker identification for ESCC improves medical care quality.
• ML supports expert diagnostic and therapeutic decision-making.
• ML advances diagnostic efficiency and intelligent healthcare.